However, women were found to have higher HbA1c and glucose variability compared with men only when treated with multiple daily injections (MDI) and not when treated with continuous subcutaneous insulin infusion (CSII), suggesting alternative insulin delivery methods should be considered to increase diabetes management adherence [69]. The gene discussed is INS; the disease is diabetes mellitus.